Sanofi Pasteur INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$9.4Mgeneral payments (2019-2025)
$732Kresearch payments (2019-2025)
53,873clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Joseph Domachowske | Syracuse, NY | Pediatric Infectious Diseases | $301,801.11 |
| Jaime Fergie | Corpus Christi, TX | Pediatric Infectious Diseases | $225,398.79 |
| Christopher Belcher | Carmel, IN | Pediatric Infectious Diseases | $189,172.98 |
| Tina Tan | Chicago, IL | Pediatric Infectious Diseases | $145,566.52 |
| Evan Anderson | Atlanta, GA | Pediatric Infectious Diseases | $133,587.30 |
| Philip Krause | Potomac, MD | Infectious Disease | $115,646.93 |
| Janak Patel | Galveston, TX | Pediatric Infectious Diseases | $113,791.61 |
| Archana Chatterjee | Sioux Falls, SD | Pediatric Infectious Diseases | $110,210.97 |
| Kamaljit Singh | Chicago, IL | Infectious Disease | $109,427.32 |
| Wayne Dankner | San Diego, CA | $108,989.86 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.